25 XP   0   0   10

Synairgen plc
Buy, Hold or Sell?

Let's analyse Synairgen together

PenkeI guess you are interested in Synairgen plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Synairgen plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Synairgen plc

I send you an email if I find something interesting about Synairgen plc.

Quick analysis of Synairgen (30 sec.)










What can you expect buying and holding a share of Synairgen? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p10.07
Expected worth in 1 year
p-23.15
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
p-33.22
Return On Investment
-511.1%

For what price can you sell your share?

Current Price per Share
p6.50
Expected price per share
p4 - p8.01
How sure are you?
50%

1. Valuation of Synairgen (5 min.)




Live pricePrice per Share (EOD)

p6.50

Intrinsic Value Per Share

p-107.71 - p18.89

Total Value Per Share

p-97.64 - p28.96

2. Growth of Synairgen (5 min.)




Is Synairgen growing?

Current yearPrevious yearGrowGrow %
How rich?$25.3m$76.3m-$50.9m-201.2%

How much money is Synairgen making?

Current yearPrevious yearGrowGrow %
Making money-$22m-$39m$17m77.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Synairgen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#548 / 1007

Most Revenue
#849 / 1007

Most Profit
#710 / 1007

Most Efficient
#293 / 1007

What can you expect buying and holding a share of Synairgen? (5 min.)

Welcome investor! Synairgen's management wants to use your money to grow the business. In return you get a share of Synairgen.

What can you expect buying and holding a share of Synairgen?

First you should know what it really means to hold a share of Synairgen. And how you can make/lose money.

Speculation

The Price per Share of Synairgen is p6.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Synairgen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Synairgen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p10.07. Based on the TTM, the Book Value Change Per Share is p-8.31 per quarter. Based on the YOY, the Book Value Change Per Share is p-11.95 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Synairgen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.11-1.7%-0.11-1.7%-0.19-3.0%-0.09-1.4%-0.06-0.9%
Usd Book Value Change Per Share-0.10-1.6%-0.10-1.6%-0.15-2.3%0.010.2%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-1.6%-0.10-1.6%-0.15-2.3%0.010.2%0.010.1%
Usd Price Per Share0.17-0.17-2.24-1.08-0.77-
Price to Earnings Ratio-1.54--1.54--15.23--13.91--9.47-
Price-to-Total Gains Ratio-1.63--1.63--8.70--11.98--13.19-
Price to Book Ratio1.34-1.34-7.45-12.14-14.74-
Price-to-Total Gains Ratio-1.63--1.63--8.70--11.98--13.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.081224
Number of shares12311
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.100.01
Usd Total Gains Per Share-0.100.01
Gains per Quarter (12311 shares)-1,277.69149.69
Gains per Year (12311 shares)-5,110.75598.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5111-51210599589
20-10222-10232011981188
30-15332-15343017961787
40-20443-20454023952386
50-25554-25565029942985
60-30665-30676035933584
70-35775-35787041914183
80-40886-40898047904782
90-45997-46009053895381
100-51108-51120059885980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.05.00.00.0%0.07.00.00.0%2.010.00.016.7%2.019.00.09.5%
Book Value Change Per Share0.01.00.00.0%1.02.02.020.0%1.04.02.014.3%3.07.02.025.0%6.013.02.028.6%
Dividend per Share0.00.01.00.0%0.00.05.00.0%0.00.07.00.0%0.00.012.00.0%0.00.021.00.0%
Total Gains per Share0.01.00.00.0%1.02.02.020.0%1.04.02.014.3%3.07.02.025.0%6.013.02.028.6%

Fundamentals of Synairgen

About Synairgen plc

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Fundamental data was last updated by Penke on 2024-04-30 14:43:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Synairgen plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Synairgen earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Synairgen to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Synairgen plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-449.1%+449.1%
5Y-449.1%10Y-1,008.4%+559.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.4%+282.4%
5Y-449.1%-434.0%-15.1%
10Y-1,008.4%-584.8%-423.6%
1.1.2. Return on Assets

Shows how efficient Synairgen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Synairgen to the Biotechnology industry mean.
  • -75.0% Return on Assets means that Synairgen generated -0.75 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Synairgen plc:

  • The MRQ is -75.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -75.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-75.0%TTM-75.0%0.0%
TTM-75.0%YOY-62.4%-12.6%
TTM-75.0%5Y-58.1%-16.9%
5Y-58.1%10Y-42.2%-15.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.0%-13.2%-61.8%
TTM-75.0%-12.7%-62.3%
YOY-62.4%-11.5%-50.9%
5Y-58.1%-13.8%-44.3%
10Y-42.2%-15.5%-26.7%
1.1.3. Return on Equity

Shows how efficient Synairgen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Synairgen to the Biotechnology industry mean.
  • -87.0% Return on Equity means Synairgen generated -0.87 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Synairgen plc:

  • The MRQ is -87.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -87.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-87.0%TTM-87.0%0.0%
TTM-87.0%YOY-73.9%-13.1%
TTM-87.0%5Y-85.2%-1.9%
5Y-85.2%10Y-60.5%-24.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-87.0%-16.7%-70.3%
TTM-87.0%-15.9%-71.1%
YOY-73.9%-14.7%-59.2%
5Y-85.2%-19.2%-66.0%
10Y-60.5%-20.0%-40.5%

1.2. Operating Efficiency of Synairgen plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Synairgen is operating .

  • Measures how much profit Synairgen makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Synairgen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Synairgen plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-562.2%+562.2%
5Y-562.2%10Y-1,192.8%+630.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--291.9%+291.9%
5Y-562.2%-485.6%-76.6%
10Y-1,192.8%-610.8%-582.0%
1.2.2. Operating Ratio

Measures how efficient Synairgen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Synairgen plc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y5.765-5.765
5Y5.76510Y115.595-109.830
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.791-3.791
5Y5.7655.675+0.090
10Y115.5957.558+108.037

1.3. Liquidity of Synairgen plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Synairgen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.19 means the company has 7.19 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Synairgen plc:

  • The MRQ is 7.191. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.191. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.191TTM7.1910.000
TTM7.191YOY15.845-8.655
TTM7.1915Y11.019-3.828
5Y11.01910Y10.227+0.792
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1913.877+3.314
TTM7.1914.178+3.013
YOY15.8455.343+10.502
5Y11.0196.135+4.884
10Y10.2276.468+3.759
1.3.2. Quick Ratio

Measures if Synairgen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Synairgen to the Biotechnology industry mean.
  • A Quick Ratio of 8.34 means the company can pay off 8.34 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Synairgen plc:

  • The MRQ is 8.343. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.343. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.343TTM8.3430.000
TTM8.343YOY4.836+3.507
TTM8.3435Y7.796+0.547
5Y7.79610Y7.097+0.700
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3433.514+4.829
TTM8.3433.998+4.345
YOY4.8365.380-0.544
5Y7.7966.135+1.661
10Y7.0976.434+0.663

1.4. Solvency of Synairgen plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Synairgen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Synairgen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Synairgen assets are financed with 13.8% credit (debt) and the remaining percentage (100% - 13.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Synairgen plc:

  • The MRQ is 0.138. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.138. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.1380.000
TTM0.138YOY0.105+0.034
TTM0.1385Y0.199-0.061
5Y0.19910Y0.173+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.339-0.201
TTM0.1380.336-0.198
YOY0.1050.271-0.166
5Y0.1990.368-0.169
10Y0.1730.388-0.215
1.4.2. Debt to Equity Ratio

Measures if Synairgen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Synairgen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.0% means that company has 0.16 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Synairgen plc:

  • The MRQ is 0.160. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.160. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.1600.000
TTM0.160YOY0.123+0.037
TTM0.1605Y0.313-0.152
5Y0.31310Y0.251+0.062
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1600.388-0.228
TTM0.1600.403-0.243
YOY0.1230.340-0.217
5Y0.3130.430-0.117
10Y0.2510.463-0.212

2. Market Valuation of Synairgen plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Synairgen generates.

  • Above 15 is considered overpriced but always compare Synairgen to the Biotechnology industry mean.
  • A PE ratio of -1.54 means the investor is paying -1.54 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Synairgen plc:

  • The EOD is -0.742. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.541. Based on the earnings, the company is expensive. -2
  • The TTM is -1.541. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.742MRQ-1.541+0.799
MRQ-1.541TTM-1.5410.000
TTM-1.541YOY-15.229+13.688
TTM-1.5415Y-13.915+12.374
5Y-13.91510Y-9.475-4.440
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.742-2.281+1.539
MRQ-1.541-2.599+1.058
TTM-1.541-2.674+1.133
YOY-15.229-4.133-11.096
5Y-13.915-6.258-7.657
10Y-9.475-6.270-3.205
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Synairgen plc:

  • The EOD is -0.925. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.921. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.921. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.925MRQ-1.921+0.996
MRQ-1.921TTM-1.9210.000
TTM-1.921YOY-11.476+9.555
TTM-1.9215Y-917.739+915.818
5Y-917.73910Y665.420-1,583.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.925-2.903+1.978
MRQ-1.921-3.323+1.402
TTM-1.921-3.552+1.631
YOY-11.476-5.592-5.884
5Y-917.739-8.378-909.361
10Y665.420-8.875+674.295
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Synairgen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.34 means the investor is paying 1.34 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Synairgen plc:

  • The EOD is 0.646. Based on the equity, the company is cheap. +2
  • The MRQ is 1.341. Based on the equity, the company is underpriced. +1
  • The TTM is 1.341. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.646MRQ1.341-0.695
MRQ1.341TTM1.3410.000
TTM1.341YOY7.446-6.105
TTM1.3415Y12.135-10.794
5Y12.13510Y14.743-2.607
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6461.911-1.265
MRQ1.3412.116-0.775
TTM1.3412.097-0.756
YOY7.4462.885+4.561
5Y12.1353.556+8.579
10Y14.7433.959+10.784
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Synairgen plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---8.305-8.3050%-11.953+44%0.973-954%0.698-1290%
Book Value Per Share--10.06810.0680%30.327-67%16.890-40%11.078-9%
Current Ratio--7.1917.1910%15.845-55%11.019-35%10.227-30%
Debt To Asset Ratio--0.1380.1380%0.105+32%0.199-31%0.173-20%
Debt To Equity Ratio--0.1600.1600%0.123+30%0.313-49%0.251-36%
Dividend Per Share----0%-0%-0%-0%
Eps---8.762-8.7620%-15.538+77%-7.464-15%-4.526-48%
Free Cash Flow Per Share---7.028-7.0280%-16.113+129%-7.711+10%-4.573-35%
Free Cash Flow To Equity Per Share---7.027-7.0270%7.791-190%19.632-136%11.757-160%
Gross Profit Margin--1.2981.2980%1.050+24%1.122+16%1.071+21%
Intrinsic Value_10Y_max--18.887--------
Intrinsic Value_10Y_min---107.713--------
Intrinsic Value_1Y_max---3.186--------
Intrinsic Value_1Y_min---10.690--------
Intrinsic Value_3Y_max---5.703--------
Intrinsic Value_3Y_min---32.398--------
Intrinsic Value_5Y_max---3.553--------
Intrinsic Value_5Y_min---54.248--------
Market Cap1308937552.000-108%2718562608.0002718562608.0000%36146813936.000-92%17451302032.571-84%12434906744.000-78%
Net Profit Margin----0%-0%-4.4910%-10.0840%
Operating Margin----0%-0%-5.6220%-11.9280%
Operating Ratio----0%-0%5.765-100%115.595-100%
Pb Ratio0.646-108%1.3411.3410%7.446-82%12.135-89%14.743-91%
Pe Ratio-0.742+52%-1.541-1.5410%-15.229+888%-13.915+803%-9.475+515%
Price Per Share6.500-108%13.50013.5000%179.500-92%86.661-84%61.750-78%
Price To Free Cash Flow Ratio-0.925+52%-1.921-1.9210%-11.476+497%-917.739+47675%665.420-100%
Price To Total Gains Ratio-0.783+52%-1.625-1.6250%-8.701+435%-11.980+637%-13.191+712%
Quick Ratio--8.3438.3430%4.836+73%7.796+7%7.097+18%
Return On Assets---0.750-0.7500%-0.624-17%-0.581-23%-0.422-44%
Return On Equity---0.870-0.8700%-0.739-15%-0.852-2%-0.605-31%
Total Gains Per Share---8.305-8.3050%-11.953+44%0.973-954%0.698-1290%
Usd Book Value--25335640.00025335640.0000%76313696.800-67%42502465.929-40%27876076.592-9%
Usd Book Value Change Per Share---0.104-0.1040%-0.149+44%0.012-954%0.009-1290%
Usd Book Value Per Share--0.1260.1260%0.379-67%0.211-40%0.138-9%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.109-0.1090%-0.194+77%-0.093-15%-0.057-48%
Usd Free Cash Flow---17684339.200-17684339.2000%-40546396.000+129%-19404718.681+10%-11508013.653-35%
Usd Free Cash Flow Per Share---0.088-0.0880%-0.201+129%-0.096+10%-0.057-35%
Usd Free Cash Flow To Equity Per Share---0.088-0.0880%0.097-190%0.245-136%0.147-160%
Usd Market Cap16356483.650-108%33971158.35033971158.3500%451690586.944-92%218071470.199-84%155386594.673-78%
Usd Price Per Share0.081-108%0.1690.1690%2.243-92%1.083-84%0.772-78%
Usd Profit---22049192.000-22049192.0000%-39099359.200+77%-18192980.133-17%-10825537.219-51%
Usd Revenue----0%-0%18.744-100%983.539-100%
Usd Total Gains Per Share---0.104-0.1040%-0.149+44%0.012-954%0.009-1290%
 EOD+3 -5MRQTTM+0 -0YOY+15 -155Y+11 -2110Y+9 -23

3.2. Fundamental Score

Let's check the fundamental score of Synairgen plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.742
Price to Book Ratio (EOD)Between0-10.646
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.343
Current Ratio (MRQ)Greater than17.191
Debt to Asset Ratio (MRQ)Less than10.138
Debt to Equity Ratio (MRQ)Less than10.160
Return on Equity (MRQ)Greater than0.15-0.870
Return on Assets (MRQ)Greater than0.05-0.750
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Synairgen plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose6.660
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets23,529
Total Liabilities3,254
Total Stockholder Equity20,275
 As reported
Total Liabilities 3,254
Total Stockholder Equity+ 20,275
Total Assets = 23,529

Assets

Total Assets23,529
Total Current Assets23,399
Long-term Assets130
Total Current Assets
Cash And Cash Equivalents 15,926
Short-term Investments 3,750
Net Receivables 3,723
Inventory -4
Other Current Assets 4
Total Current Assets  (as reported)23,399
Total Current Assets  (calculated)23,399
+/-0
Long-term Assets
Property Plant Equipment 86
Intangible Assets 44
Long-term Assets Other 0
Long-term Assets  (as reported)130
Long-term Assets  (calculated)130
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,254
Long-term Liabilities3,254
Total Stockholder Equity20,275
Total Current Liabilities
Accounts payable 1
Other Current Liabilities 3,253
Total Current Liabilities  (as reported)3,254
Total Current Liabilities  (calculated)3,254
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,254
Long-term Liabilities  (calculated)0
+/- 3,254
Total Stockholder Equity
Common Stock2,014
Retained Earnings -106,984
Accumulated Other Comprehensive Income 0
Other Stockholders Equity 125,245
Total Stockholder Equity (as reported)20,275
Total Stockholder Equity (calculated)20,275
+/-0
Other
Capital Stock2,014
Cash and Short Term Investments 19,676
Common Stock Shares Outstanding 201,360
Liabilities and Stockholders Equity 23,529
Net Debt -15,926
Net Invested Capital 20,275
Net Tangible Assets 20,231
Net Working Capital 20,145
Property Plant and Equipment Gross 86



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-12-312021-12-312021-03-302020-12-312020-03-302019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-30
> Total Assets 
633
9,238
8,181
6,726
4,772
8,666
6,091
5,916
3,807
2,036
9,931
8,283
5,545
7,662
6,804
4,071
0
88,548
0
44,638
23,529
23,52944,638088,54804,0716,8047,6625,5458,2839,9312,0363,8075,9166,0918,6664,7726,7268,1819,238633
   > Total Current Assets 
484
9,063
7,988
6,481
4,541
8,458
5,758
5,616
3,448
1,724
9,812
8,185
5,470
7,605
6,401
3,499
3,499
88,160
88,160
44,412
23,399
23,39944,41288,16088,1603,4993,4996,4017,6055,4708,1859,8121,7243,4485,6165,7588,4584,5416,4817,9889,063484
       Cash And Cash Equivalents 
407
78
33
1,020
557
5,963
1,334
1,492
1,656
834
2,847
3,992
3,104
4,845
5,284
2,454
0
74,976
0
33,827
15,926
15,92633,827074,97602,4545,2844,8453,1043,9922,8478341,6561,4921,3345,9635571,0203378407
       Short-term Investments 
350
8,605
7,464
4,998
3,445
1,977
3,680
3,401
1,431
458
6,752
3,722
1,661
2,000
50
0
0
0
0
0
3,750
3,75000000502,0001,6613,7226,7524581,4313,4013,6801,9773,4454,9987,4648,605350
       Net Receivables 
0
0
0
0
0
0
0
0
0
196
73
320
609
432
876
1,004
1,004
13,143
13,143
10,585
3,723
3,72310,58513,14313,1431,0041,00487643260932073196000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
704
1,011
1
0
13
0
11
4
411013011,0117040000000000000
   > Long-term Assets 
149
175
193
245
231
208
333
300
359
312
119
98
75
57
403
572
0
388
0
226
130
13022603880572403577598119312359300333208231245193175149
       Property Plant Equipment 
145
154
157
146
122
81
81
60
27
15
17
17
13
12
374
556
556
344
344
173
86
86173344344556556374121317171527608181122146157154145
       Intangible Assets 
4
21
36
99
109
127
252
240
332
297
102
81
62
45
29
16
0
44
0
53
44
4453044016294562811022973322402521271099936214
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000
> Total Liabilities 
163
398
344
472
585
667
527
922
391
457
495
936
860
1,103
777
1,818
0
3,407
0
7,638
3,254
3,2547,63803,40701,8187771,103860936495457391922527667585472344398163
   > Total Current Liabilities 
163
398
334
464
580
665
527
922
391
457
495
936
860
1,103
777
1,691
1,691
3,407
3,407
7,638
3,254
3,2547,6383,4073,4071,6911,6917771,103860936495457391922527665580464334398163
       Short-term Debt 
0
0
3
2
2
3
2
0
0
0
0
0
0
0
0
201
0
128
0
0
0
0001280201000000002322300
       Accounts payable 
0
0
0
0
0
0
0
0
0
20
78
281
356
282
305
161
1,490
1,541
3,279
4,157
1
14,1573,2791,5411,4901613052823562817820000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
821
472
1,329
0
1,738
0
3,481
3,253
3,2533,48101,73801,3294728210000000000000
   > Long-term Liabilities 
0
0
10
8
5
2
0
0
0
0
0
0
0
0
305
127
0
3,407
0
4,157
3,254
3,2544,15703,4070127305000000002581000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
1,579
9,436
7,347
4,685
6,559
6,027
2,253
0
85,141
0
37,000
20,275
20,27537,000085,14102,2536,0276,5594,6857,3479,4361,579000000000
   Common Stock
0
0
0
0
0
0
0
0
0
752
913
913
914
914
1,094
1,094
1,094
1,999
1,999
2,013
2,014
2,0142,0131,9991,9991,0941,0941,094914914913913752000000000
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 
-2
-35
-81
-141
-209
-127
-161
-193
-147
-162
-140
-150
-159
-166
-190
0
0
0
0
0
0
000000-190-166-159-150-140-162-147-193-161-127-209-141-81-35-2
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
483
483
483
483
26,420
28,935
28,262
483
125,245
483
125,245
125,245
125,245125,245483125,24548328,26228,93526,420483483483483000000000



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-102
Gross Profit-102-102
 
Operating Income (+$)
Gross Profit-102
Operating Expense-20,198
Operating Income-20,300-20,300
 
Operating Expense (+$)
Research Development14,927
Selling General Administrative5
Selling And Marketing Expenses5,266
Operating Expense20,19820,198
 
Net Interest Income (+$)
Interest Income207
Interest Expense-207
Other Finance Cost-207
Net Interest Income207
 
Pretax Income (+$)
Operating Income-20,300
Net Interest Income207
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-20,093-20,507
EBIT - interestExpense = -20,507
-20,093
-17,438
Interest Expense207
Earnings Before Interest and Taxes (EBIT)-20,300-19,886
Earnings Before Interest and Taxes (EBITDA)-20,198
 
After tax Income (+$)
Income Before Tax-20,093
Tax Provision--2,448
Net Income From Continuing Ops-17,645-17,645
Net Income-17,645
Net Income Applicable To Common Shares-17,645
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses20,300
Total Other Income/Expenses Net207-207
 

Technical Analysis of Synairgen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Synairgen. The general trend of Synairgen is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Synairgen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Synairgen plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8 < 8.01 < 8.01.

The bearish price targets are: 5.99 > 4.5 > 4.

Tweet this
Synairgen plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Synairgen plc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Synairgen plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Synairgen plc.

Synairgen plc Daily Moving Average Convergence/Divergence (MACD) ChartSynairgen plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Synairgen plc. The current adx is .

Synairgen plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Synairgen plc.

Synairgen plc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Synairgen plc.

Synairgen plc Daily Relative Strength Index (RSI) ChartSynairgen plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Synairgen plc.

Synairgen plc Daily Stochastic Oscillator ChartSynairgen plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Synairgen plc.

Synairgen plc Daily Commodity Channel Index (CCI) ChartSynairgen plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Synairgen plc.

Synairgen plc Daily Chande Momentum Oscillator (CMO) ChartSynairgen plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Synairgen plc.

Synairgen plc Daily Williams %R ChartSynairgen plc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Synairgen plc.

Synairgen plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Synairgen plc.

Synairgen plc Daily Average True Range (ATR) ChartSynairgen plc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Synairgen plc.

Synairgen plc Daily On-Balance Volume (OBV) ChartSynairgen plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Synairgen plc.

Synairgen plc Daily Money Flow Index (MFI) ChartSynairgen plc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Synairgen plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Synairgen plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Synairgen plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose6.660
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Synairgen with someone you think should read this too:
  • Are you bullish or bearish on Synairgen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Synairgen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Synairgen plc

I send you an email if I find something interesting about Synairgen plc.


Comments

How you think about this?

Leave a comment

Stay informed about Synairgen plc.

Receive notifications about Synairgen plc in your mailbox!